Tabula Rasa Ventures
Overview
Tabula Rasa Ventures is a venture capital firm focused on capitalizing the next generation of health innovation, investing in opportunities across technology, digital therapeutics, healthcare infrastructure, and drug development.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| 2A Biosciences | Mar 2023 | Seed | Co-investor |
| Lykos Therapeutics | Jan 2024 | Series A | - |
| Enthea | Dec 2022 | Seed | Lead |
| Natural MedTech | Jan 2021 | Accelerator | Lead |
| Wavepaths | Nov 2021 | Seed | Co-investor |
Key People
Marik Hazan
Founder
Maria Velkova
Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Tabula Rasa Ventures based?
Tabula Rasa Ventures is headquartered in New York City, New York, United States.
When was Tabula Rasa Ventures founded?
Tabula Rasa Ventures was founded in 2019.
How many portfolio companies does Tabula Rasa Ventures have?
Tabula Rasa Ventures has 5 portfolio companies in Caplight's dataset.
What are some companies in Tabula Rasa Ventures's portfolio?
Portfolio companies visible on Caplight include 2A Biosciences, Lykos Therapeutics, Enthea, Natural MedTech, Wavepaths.
What was Tabula Rasa Ventures's most recent investment shown here?
Tabula Rasa Ventures's most recent investment in this portfolio sample was in Lykos Therapeutics in 2024.
What sectors does Tabula Rasa Ventures focus on?
Tabula Rasa Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Media, Entertainment & Gaming, FinTech.
What company stages does Tabula Rasa Ventures focus on?
Tabula Rasa Ventures typically invests at the Early stage.
What is Tabula Rasa Ventures's AUM?
Tabula Rasa Ventures's assets under management are estimated between $0.0 and $50.0M.